REQUEST A DEMO
Total
USD $0.00
Search more companies

Klovermed Severo-Zapad OOO (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Klovermed Severo-Zapad OOO Profile Updated: August 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Klovermed Severo-Zapad OOO is a company in Russia, with a head office in Saint Petersburg. It operates in the Pharmacies and Drug Stores sector. The company was established on October 05, 2015. In its most recent financial highlights, the company reported a net sales revenue increase of 33.08% in 2023. Its’ total assets recorded a growth of 14.95%. The enterprise’s net profit margin decreased by 3.43% in 2023.

Headquarters
Marata, 47-49, A, S205
Saint Petersburg; Saint Petersburg; Postal Code: 191002

Contact Details: Purchase the Klovermed Severo-Zapad OOO report to view the information.

Basic Information
Outstanding Shares:
Purchase the Klovermed Severo-Zapad OOO report to view the information.
Registered Capital:
Purchase the Klovermed Severo-Zapad OOO report to view the information.
Incorporation Date:
October 05, 2015
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Klovermed Severo-Zapad OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
33.08%
Total operating revenue
33.08%
Operating profit (EBIT)
25.48%
Net Profit (Loss) for the Period
17.14%
Total assets
14.95%
Total equity
-0.77%
Operating Profit Margin (ROS)
-1.72%
Net Profit Margin
-3.43%
Return on Equity (ROE)
15.2%
Quick Ratio
-1.3%
Cash Ratio
-1.43%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?